• Chair of the Board of Novonesis A/S.
• Chair of the Board of Meatable.
• Member of the Board of Oterra.
• Venture Partner, Forbion BioEconomy Fund I.

• President and CEO of Chr. Hansen, 2013-2018.
• COO and member of the Board of Crucell, 2007-2011.
• Group Vice President and member of the Board of Quest-International / ICI, 2003-2007.
• President of Industrial Products at Campina, 2000-2002.
• President of Anti-infectives at DSM, 1998-1999.
• Managing Director of the Industrial Pharmaceutical Division at Royal Gist-Brocades and member of the Executive Committee, 1996-1998.

• Considered independent under the Danish Corporate Governance Recommendations.
• Member of the Board of Directors since November 2025. Vice Chair of the Board of Directors since November 2025. 
• Member of the Chair Committee since November 2025.
• Member of the Audit Committee since November 2025.
• Member of the Remuneration Committee and Chair of the Remuneration Committee since November 2025.

• Global corporate leadership.
• Finance & accounting.
• Business development, M&A and external innovation sourcing.
• Environmental, social & governance (ESG).
• Human capital management.

• 1987: MD, Medical Faculty from the Erasmus University Rotterdam, Netherlands.
• 1989: MBA from Rotterdam School of Management, Erasmus University Rotterdam.
• 2018: Nyenrode Business University NED program (Commissarissen-cyclus).

Dutch. Born in 1961. Male.